FDA Clears Absorbable Hemostatic Bone Putty From Abyrx,™Inc.

Newly cleared AHBP is ready-to-use and achieves hemostasis by mechanical tamponade. Its proprietary formulation is comprised of water soluble and dispersible components that are fully synthetic and substantially absorb within days following surgery.

Abyrx,™ Inc. Receives FDA 510(k) Clearance for New Absorbable Hemostatic Bone Putty (AHBP™) (via PR Newswire)

IRVINGTON, N.Y., June 12, 2013 /PRNewswire/ — Abyrx, Inc., a privately-held therapeutic device company, today announced that the United States Food and Drug Administration has cleared its new Absorbable Hemostatic Bone Putty (AHBP) for clinical use in the United States. AHBP is provided ready-to-…

published: June 13, 2013 in: Approval/Clearance, Orthopaedics

Most read

Latest

^